ACM Research to Announce Preliminary 2025 Revenue Range and 2026 Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 29 2025
0mins
Should l Buy ACMR?
Source: Globenewswire
- Revenue Forecast Announcement: ACM Research plans to release its preliminary revenue range for fiscal year 2025 before the U.S. market opens on January 22, 2026, which is expected to enhance investor confidence in the company's financial health by providing initial guidance on future performance.
- 2026 Outlook: The company will also provide its first revenue outlook for 2026, a move that not only reflects ACM's confidence in future growth but may also attract more investor interest in its long-term development potential.
- Conference Participation: ACM will participate virtually in the 28th Annual Needham Growth Conference on January 15, 2026, and host one-on-one meetings, aiming to enhance investor engagement through direct communication and improve market understanding of its strategic direction.
- Showcasing Technical Strength: As a leading supplier for semiconductor and advanced packaging applications, ACM's product offerings span cleaning, electroplating, and stress-free polishing, showcasing its technical capabilities in improving semiconductor manufacturing efficiency and product yield, thereby solidifying its market position.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ACMR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ACMR
Wall Street analysts forecast ACMR stock price to fall
6 Analyst Rating
5 Buy
1 Hold
0 Sell
Strong Buy
Current: 64.100
Low
36.00
Averages
41.80
High
45.00
Current: 64.100
Low
36.00
Averages
41.80
High
45.00
About ACMR
ACM Research, Inc. develops, manufactures and sells semiconductor process equipment spanning cleaning, electroplating, stress-free polishing, vertical furnace processes, track, plasma-enhanced chemical vapor deposition (PECVD), and wafer- and panel-level packaging tools, enabling advanced and semi-critical semiconductor device manufacturing. It has also developed Timely Energized Bubble Oscillation (TEBO) technology for application in wet wafer cleaning during the fabrication of two-dimensional (2D) and three-dimensional wafers with fine feature sizes. It has designed these tools for use in fabricating foundry, logic, and memory chips, including dynamic random-access memory (DRAM), 3D NAND-flash memory chips, and compound semiconductor chips. It also develops, manufactures, and sells a range of advanced packaging tools to wafer assembly and packaging customers. Its other advanced packaging tools include Ultra ECP ap, Ultra C Developer, and Ultra C PR Megasonic-Assisted Stripper.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Overseas Opportunities: Beeneet Kothari, founder of Tekne Capital Management, suggests that the best tech investment opportunities are currently found outside the U.S.
- Investor Mindset: The article highlights a common instinct among investors to focus on U.S. technology stocks, contrasting it with Kothari's perspective on global markets.
See More
- ACMR Options Volume: ACM Research Inc (ACMR) has seen an options trading volume of 8,259 contracts today, representing approximately 825,900 shares, which is about 53.7% of its average daily trading volume of 1.5 million shares over the past month, indicating heightened market interest in its future performance.
- High Frequency Trading: Within ACMR, the $80 strike call option has been particularly active, with 2,496 contracts traded today, equating to approximately 249,600 shares, suggesting strong bullish sentiment among investors at this price level.
- ALDX Options Activity: Concurrently, Aldeyra Therapeutics Inc (ALDX) has recorded an options trading volume of 4,196 contracts, representing around 419,600 shares, which is approximately 53.3% of its average daily trading volume of 787,615 shares over the past month, reflecting investor interest in its stock.
- ALDX High Frequency Trading: For ALDX, the $4 strike put option has seen a trading volume of 2,473 contracts, approximately 247,300 shares, indicating bearish sentiment in the market, possibly linked to uncertainties surrounding the company's future.
See More
- Options Selling Risk: Selling puts on ACM Research Inc. does not provide the same upside potential as owning shares, as the put seller only acquires shares if the contract is exercised, indicating a disparity between risk and reward in options trading.
- Exercise Condition Analysis: The put seller will only acquire shares at a cost basis of $28.50 if ACM Research Inc.'s stock price falls by 42.2% and the contract is exercised, meaning that the primary benefit of selling the option comes from the premium collected rather than stock ownership.
- Annualized Yield: The annualized return from selling this put option is 9.4%, which may be considered relatively attractive in the current market environment, but it is essential to factor in the historical volatility of ACM Research Inc.
- Volatility Assessment: With a trailing twelve-month volatility of 73% based on the last 250 trading days' closing prices, ACM Research Inc. exhibits significant price fluctuations, prompting investors to carefully evaluate the potential risks and rewards when considering selling options.
See More
- 2025 Revenue Outlook Adjustment: ACM Research revised its 2025 revenue outlook to $885 million to $900 million, up from $875 million to $925 million, although still below the consensus of $904.47 million, indicating a cautiously optimistic view on future market conditions.
- 2026 Revenue Projection: The company anticipates 2026 revenue to reach $1.080 billion to $1.175 billion, exceeding the street view of $1.05 billion, reflecting management's confidence in market share gains from newer products, particularly in single-wafer SPM cleaners and Tahoe cleaning tools.
- Investment Acceleration: ACM plans to accelerate investments in Oregon to support the industry's shift towards domestic semiconductor manufacturing, which is expected to enhance the company's competitiveness and production capacity.
- Stock Performance: ACM Research shares rose 2.39% to $54.73 in premarket trading on Thursday, nearing its 52-week high of $54.82, demonstrating positive investor sentiment towards the company's outlook.
See More
- Revenue Outlook Adjustment: ACM Research has revised its 2025 revenue outlook to $885M-$900M, tightening from the previous range of $875M-$925M, indicating a cautious optimism regarding market demand.
- 2026 Projections: The company anticipates 2026 revenue to reach $1.08B-$1.175B, exceeding the consensus estimate of $1.06B, reflecting strong growth potential from products like single-wafer SPM cleaning tools.
- CEO Insights: CEO Dr. David Wang highlighted contributions from single-wafer SPM cleaning tools, Tahoe cleaning tools, and Furnace series tools, while stable wafer fab equipment spending provides a favorable market environment for growth.
- Stock Performance: ACM Research's stock traded 1.9% higher during Thursday's pre-market hours, reflecting positive market sentiment towards the company's outlook, which is expected to set a solid foundation for the upcoming Q4 and annual results release.
See More
- Revenue Outlook Adjustment: ACM Research has revised its 2025 revenue forecast to a range of $885 million to $900 million, down from the previous estimate of $875 million to $925 million, reflecting a cautious assessment of market demand.
- 2026 Projections: The company anticipates 2026 revenue between $1.080 billion and $1.175 billion, based on management's evaluation of international trade policies, customer spending plans, and supply chain conditions, indicating confidence in future growth.
- Positive Market Reaction: ACMR shares rose over 1% in pre-market trading after closing at $53.45 on Wednesday, up 4.48% from the previous day, suggesting investor optimism regarding the company's outlook.
- Growth Strategy: CEO David Wang stated that the company plans for a higher revenue growth rate in 2026, driven by healthy investments in production capacity and market share gains from newer products, demonstrating a proactive approach to future development.
See More








